Introduction
Histoplasma cupsulatum, a thermally dimorphic fungal pathogen. causes histoplasmosis in man. Infection is established by inhalation of conidia from the soil-inhabiting saprophytic mycelial stage. In the lungs, conidia transform into the parasitic yeast form, which causes disease that ranges from a benign infection to chronic cavitation or disseminated infection. Reactivation of previously controlled histoplasmosis has recently become a serious problem in patients with the acquired immune deficiency syndrome (AIDS).1. 2 H . cupsulatum yeasts survive and multiply in human macrophages." However, there is evidence that cytokine-treated macrophages inhibit intracellular multiplication. 4 To further define the role for human macrophages in histoplasmosis, the interaction of macrophages derived from monocytes, in the presence or absence of macrophage colony-stimulating-factor (MCSF), and H . cupsulatum in t'itro was studied. A coculture technique previously developed for the study of human macrophages and H . cupsulatum was used.5
Materials and methods

Monocyte-derived macrophages
Peripheral blood mononuclear cells (PBMC) were isolated from heparinised (30 U/ml) blood from healthy human donors, without any history of histoplasmosis, by density gradient centrifugation (Histopaque, Sigma). The PBMC were washed twice in RPMI-1640 (Bio-Whittaker Lab., Walkerville, MD, USA). The PBMC were then adjusted to 5 x lo6 cells/ml in complete tissue culture medium (CTCM) (RPMI-1640 with penicillin 100 U/ml, streptomycin 100 pg/ml and fresh autologous serum 10 YO).
Briefly, 0-25 ml of the suspension of PBMC in CTCM was dispensed into each chamber of eight-chamber Lab-Tek chamber slides (Nunc Inc., Naperville, IL, USA), and incubated for 2 h at 37°C in CO, 5 % and air 95 %. After incubation, the non-adherent cells were removed by aspiration and each well was washed once with RPMI-1640. The number of adherent cells per well comprised c. 19 % of the PBMC (9.5 x lo4 cells/ chamber).
Treatment of monocytes
Duplicate wells of adherent PBMC were cultured in CTCM or CTCM containing increasing concentra-IP: 54.70.40.11
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tions of human recombinant MCSF (specific activity 1.9 x lo6 U/mg of protein; Genetics Institute, Cambridge, MA, USA). After incubation for 5 days at 37°C in air 95 O h and CO, 5 %, culture supernates were aspirated and monolayers of monocyte-derived macrophages were tested for fungicidal or fungistatic activity against H . capsulatum. Preliminary experiments showed that a 5-day treatment with MCSF was optimal for induction of killing activity.
H . capsulatum
A well characterised isolate of H . capsulatum (G217B, ATCC 26032) was used. The organism was grown on supplemented brain heart infusion (S-BHI) agar plates at 37°C. S-BHI consisted of 445 ml of BHI agar with 50 ml of bovine serum albumin 1 % and 10 ml of a H . capsulatum culture filtrate as reported by Kwon-Chung and Tewari.6 Fresh yeast cells, harvested after growth for 2 days, were washed with saline, and fungal units were counted in a haemocytometer. 
Fungicidal assay
After the 5-day treatment period, monolayers of macrophages were challenged with 0.25 ml of yeast cell suspension. At the time of challenge, scavengers of superoxide anion (superoxide dismutase ; SOD), H,O, (catalase; CAT) or a competitive inhibitor of Larginine (NMMA) were added to different sets of wells. After incubation for 3 h at 37°C in CO, 5 % , non-adherent H . capsulatum cells were aspirated and the monolayer was washed once with RPMI-1640. The aspirate plus the rinse material was cultured to determine the number of non-adherent fungal units. Macrophage monolayers with ingested or adherent fungal units were harvested with five washes of sterile water to lyse macrophages. Different dilutions of harvested materials were plated on S-BHI agar plates. The plates were dried for 1 day at 35°C and then incubated at 37°C for 5 days. The number of cfu/plate were counted and the number of cfu/culture was calculated. The percentage killing was determined by the formula [ 1 -(cfu from experimental cultures/cfu from inoculum)] x 100.
Assessment of in tracellular multiplication of H . capsulaturn
Duplicate macrophage monolayer cultures established in Lab-Tek chambers were challenged with H . capsulatum as described above. After incubation for 3 h to allow ingestion, sets of monolayers were washed with phosphate-buffered saline (PBS), dried and stained with Diff-Quik (Baxter Corporation, McGaw Park, IL, USA) for baseline data. Other sets of washed cultures were incubated with CTCM for 24 h and processed for microscopic examination as above. The number of yeast cells/macrophage was recorded in control and experimental monolayers for 3-h (baseline) and 24-h cultures. Duplicate recordings of macrophages with ingested yeast cells from duplicate chambers, 100 macrophages per recording (n = 4) were used to calculate the mean and SD of yeast cells/macrophage.
Fungistatic assay
After the challenge and exposure to inhibitors of fungicidal activity, co-cultures were incubated for 24 h. Non-adherent and adherent-ingested yeast cells in monolayers were collected as before. The harvested material was plated on S-BHI plates and incubated at 37°C for 5-7 days. The number of cfu/culture was calculated and fungistasis was determined by the formula : [ 1 -(cfu from experimental culture/cfu from control culture)] x 100.
Stat is tical analysis
Comparison between groups was made by Student's t test.
Results
Efect of MCSF on fungicidal activity of macrophages
When monocytes were cultured for 5 days in the presence of increasing concentrations of MCSF (1000, 5000, 10000 U/ml), fungicidal activity for H . capsulatum increased in a dose-dependent manner (table I). Macrophages derived from cells treated with MCSF 5000 U/ml had significant killing (46 SD 15 YO) (p < 0-02) compared to control macrophages. The killing by macrophages derived from cells treated with MCSF 10000 U/ml was significantly increased (73 SD 3 YO) (p < 0.05) compared to killing by macrophages derived from cells treated with MCSF 5000 U/ml (table I) .
Killing of adherent-ingested H . capsulatum by MCSF macrophages
When the number of non-adherent cfu of H. capsulatum was determined there was no significant difference between the experimental groups ( fig. 1) . In contrast, the number of cfu from the adherent-ingested yeast cells in MCSF-derived macrophages decreased in an MCSF dose-dependent manner ( fig. 1, table I ). This indicates that the major effect of MCSF on macrophages was killing of adherent-ingested yeast cells. The killing by macrophages treated with MCSF 5000 U/ml was 55% (p < 0.02). Reduction of adherent-ingested cfu from MCSF-activated macrophage co-cultures was not due to clumping of yeast cells in harvested material that was plated. Microscopic examination of harvested material showed that the morphology of fungal units was similar to that of the inoculum.
Killing mechanism of MCSF-actiuated macrophages
When MCSF-derived macrophages were challenged with H . capsulatum in the presence of SOD, CAT or NMMA, it was found that only SOD significantly inhibited killing by 38% (p < 0.05) ( (p < 0.001) fungistatic activity with increasing concentration of MCSF (table 111) . On increasing the dose of MCSF from 5000 to 10000 U/ml, fungistasis was increased from 25(SD1)?40 to 34*6(SD4)% (p < 0.05).
Fungistasis of adherent-ingested H . capsulatum by MCSF-activated macrophages
When the number of non-adherent cfu of H . capsulatum was determined there was no significant difference between experimental groups ( fig. 2) . In contrast, the number of cfu from adherent-ingested yeast cells was decreased by MCSF-activated macrophages when compared to control macrophages. On challenging MCSF (5000 U/ml)-activated macrophages in the presence of a potential antagonist (NMMA), fungistasis was not abrogated (fig. 2 ). However, CAT had some inhibitory effect on fungistasis, but this was not significant. In two other experiments, where macrophages were activated with MCSF, 10000 U/ml, CAT and SOD failed to inhibit fungistatic activity significantly. MCSF-activated macrophage fungistasis was 33(SD5) 'YO, in the presence of CAT it was 38(SD5) ' YO and in the presence of SOD it was 57(SD13)%.
Microscopic studies
Compared to the morphology of CTCM monocytederived macrophages (not shown), MCSF-treated monocyte-derived macrophages (5000 U/ml, fig. 3A ; 10000 U/ml, fig. 3B ) had a differentiated morphology as demonstrated by increased size and spreading. Macrophages from monocytes treated with MCSF at 10000 U/ml ( fig. 3B) were distinctly larger and more elongated than those from monocytes treated with 5000U/ml (fig. 3A) . The number of yeast cells/macrophage after a 2-h ingestion period ( fig. 3A) illustrates the starting point in a challenge experiment. Groups of yeast cells in macrophages after incubation for 24 h ( fig. 3B ) illustrate some intracellular multiplication.
Discussion
The present study demonstrates the ability of MCSF to activate human macrophages, during in-vitro differentiation from monocytes, to kill H . capsuiatum yeast cells in a dose-dependent manner. The fungicidal activity of activated human macrophages for H . capsufatunz was demonstrated by : firstly, the use of a short-term 3-h assay period which was less than the doubling time of H . capsulatum, and secondly by the use of a culture methodology for cfu determination, demonstrating killing of H . capsulatum during a 3-h incubation period that would go undetected by microscopic techniques. This demonstration brings a better understanding of host resistance to H . capsulatum.
The ability of SOD (scavenger of 02-) to inhibit the killing of adherent-ingested yeast cells by human macrophages provides evidence for a superoxidedependent mechanism of MCSF stimulation. The evidence of a superoxide anion-dependent mechanism for the killing of H . capsdatum by y-interferonactivated human macrophages has been reported previously.' It is unlikely that the nitric oxide-dependent pathway, reported to be involved in the killing of several intracellular parasites by mouse peritoneal macro phage^,^.' is involved in the killing of H . capsulatum because NMMA, a competitive inhibitor of the substrate for nitric oxide ~ynthase,~ did not inhibit killing of H . capsulatum by MCSF-activated human macrophages. Catalase, a scavenger of H,O,, also had no effect on killing. These results demonstrate a superoxide anion-dependent histoplasmacidal mechanism in macrophages.
Treatment with MCSF for 5 days during differentiation from monocytes enhanced the fungistatic activity of human macrophages in a dosedependent manner. Similar results have been reported by Newman and Gootee.lo No significant role for SOD, NMMA or CAT in the inhibition of fungistatic activity of activated human macrophages could be demonstrated.
In the present study, inhibition of multiplication or fungistasis was determined by a 24-h culture method where cfu were enumerated. Other studies have used an indirect method of measuring the inhibition of yeast cell multiplication, where yeast cells were labelled with 3H-leucine during co-culture with macrophages. Results were similar to those reported here. Recently, it has been demonstrated that bronchoalveolar macrophages (BAM) cultured with MCSF (5000 U/ml) significantly restricted intracellular multiplication of H. capsulatum,12 without inducing dramatic morphological changes in BAM. The antihistoplasmal activity of MCSF-treated murine BAM or PM could not be abrogated by NMMA. In this
